Figure 1:

Figure 2:

Results of multi-site summer fluopyram program study, 2022–2023_
| Location | Treatment | % Canopy BLD symptoms | % Fine twig dieback | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| N | 2022a | N | 2023 | P-valueb | N | 2022 | N | 2023 | P-value | ||
| Chagrin Falls, OH | Non-treated | 9 | 64.44 ± 7.66 A | 9 | 88.89 ± 3.51 A | = 0.0005 | 9 | 40.56 ± 6.69 A | 9 | 51.67 ± 5.59 A | = 0.0143 |
| Summer Program | 12 | 69.17 ± 5.11 A | 11 | 34.18 ± 10.35 B | 12 | 47.5 ± 6.17 A | 11 | 28.64 ± 6.47 B | |||
| Fairfield, CT | Non-treated | 8 | 75.63 ± 8.21 A | 4 | 84 ± 10.02 A | < 0.0001 | 8 | 63.75 ± 5.96 A | 4 | 77.00 ± 2.38 A | = 0.0046 |
| Summer Program | 11 | 66.36 ± 8.66 A | 11 | 5.91 ± 0.61 B | 11 | 56.82 ± 5.81 A | 11 | 27.73 ± 7.53 B | |||
| New London, CT | Non-treated | 9 | 8.33 ± 1.44 A | 8 | 76.06 ± 9.27 A | = 0.9009 | 9 | 5 ± 0 A | 8 | 50.31 ± 11.11 A | = 0.8592 |
| Summer Program | 14 | 13.93 ± 3.28 A | 14 | 75.75 ± 4.49 A | 14 | 5 ± 0 A | 14 | 51.07 ± 6.86 A | |||
Results of fluopyram-based management programs implemented at three seasonal timings in Perry, OH, and Chardon, OH, 2023–2024_
| Treatmenta | N | % Canopy BLD symptoms | N | % Fine twig diebackc | ||
|---|---|---|---|---|---|---|
| 2023b | 2024 | 2023 | 2024 | |||
| Spring | 14 | 75 ± 5.3 A | 18.2 ± 6.2 B | 8 | 25.6 ± 5.6 A | 8.94 ± 1.37 A |
| Spring & Summer | 15 | 54.7 ± 7 A | 6 ± 1.2 B | 8 | 24.4 ± 6.5 A | 5.63 ± 1.03 A |
| Summer | 13 | 58.5 ± 7.7 A | 10.2 ± 3.7 B | 8 | 30.6 ± 5.4 A | 6.75 ± 0.98 A |
| Non-treated | 14 | 54.3 ± 6.3 A | 41.5 ± 7.7 A | 8 | 16.9 ± 4.4 A | 9.88 ± 1.63 A |
| P-valued | P = 0.0982 | P < 0.0001 | P = 0.3843 | P = 0.0966 | ||
Results of fluopyram-based management programs, implemented at three seasonal timings, in Perry, OH, and Chardon, OH, 2023–2024_
| Treatmenta | N | Lcm/cm2 | Lcm/g2 |
|---|---|---|---|
| 2023––Foliageb | 2024––Bud | ||
| Spring | 14 | 0.25 ± 0.25 B | 31.29 ± 17.15 B |
| Spring & Summer | 15 | 0 ± 0 B | 25.73 ± 9.04 B |
| Summer | 13 | 9.65 ± 3.83 AB | 30.46 ± 18.29 B |
| Non-treated | 14 | 46.24 ± 24.67 A | 143.86 ± 54.07 A |
| P-valuec | P = 0.0005 | P = 0.0105 |
Results of fluopyram application rate study performed on Long Island, NY, 2023–2024_
| Treatment | N | % Canopy BLD symptoms | % Fine twig dieback | ||
|---|---|---|---|---|---|
| 2023a | 2024 | 2023 | 2024 | ||
| Broadform (0.08 mL/L) | 10 | 77.1 ± 7.15 A | 9.3 ± 2.6 B | 4.8 ± 2.92 A | 1.3 ± 0.68 B |
| Broadform (0.16 mL/L) | 10 | 83.1 ± 6.36 A | 10.9 ± 2.39 B | 6.4 ± 2.54 A | 0.8 ± 0.55 B |
| Broadform (0.32 mL/L) | 10 | 83 ± 6.08 A | 10.23 ± 2.62 B | 7.9 ± 3.05 A | 1.8 ± 0.76 B |
| Broadform (0.47 mL/L) | 10 | 84.4 ± 5.96 A | 6.6 ± 1.49 B | 5 ± 1.95 A | 2.5 ± 2.01 B |
| Non-treated | 10 | 84.38 ± 7.24 A | 89.3 ± 2.99 A | 6.5 ± 1.92 A | 22.4 ± 7.01 A |
| P-valueb | P = 0.9300 | P < 0.0001 | P = 0.9071 | P < 0.0001 | |